Novavax, Inc. (NVAX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference TranscriptSeeking Alpha • 09/09/26
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?24/7 Wall Street • 09/01/26
Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination SeasonPRNewsWire • 08/28/26
NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook RaisedZacks Investment Research • 08/07/26
Novavax Reports Second Quarter 2026 Financial Results and Operational HighlightsPRNewsWire • 08/06/26
Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 07/20/26
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research • 07/08/26
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?24/7 Wall Street • 06/16/26
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You TradeZacks Investment Research • 06/12/26
Novavax (NVAX) Up 10.4% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/05/26
Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/04/26